MAUNA KEA TECHNOLOGIES (ALMKT.PA) Stock Price, Forecast & Analysis
EPA:ALMKT • FR0010609263
ALMKT.PA Key Statistics, Chart & Performance
The current stock price of ALMKT.PA is 0.1738 EUR. In the past month the price increased by 27.23%. In the past year, price decreased by -1.03%.
ALMKT.PA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ALMKT.PA. When comparing the yearly performance of all stocks, ALMKT.PA is one of the better performing stocks in the market, outperforming 96.36% of all stocks.
ALMKT.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALMKT.PA. Both the profitability and financial health of ALMKT.PA have multiple concerns.
ALMKT.PA Financial Highlights
Over the last trailing twelve months ALMKT.PA reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS decreased by -114.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -82.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALMKT.PA Forecast & Estimates
9 analysts have analysed ALMKT.PA and the average price target is 0.36 EUR. This implies a price increase of 105.41% is expected in the next year compared to the current price of 0.1738.
ALMKT.PA Ownership
ALMKT.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 15.85 | 107.471B | ||
| SHL | SIEMENS HEALTHINEERS AG | 14.98 | 46.665B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 17.51 | 25.662B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 16.88 | 25.325B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 17.26 | 25.287B | ||
| BIM | BIOMERIEUX | 19.65 | 11.954B | ||
| DIA | DIASORIN SPA | 17.06 | 3.97B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.48 | 3.711B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 10.84 | 2.308B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.88 | 1.672B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About ALMKT.PA
Company Profile
Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2011-07-05. The firm specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. The company provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.
Company Info
MAUNA KEA TECHNOLOGIES
9, rue d'Enghien
Paris ILE-DE-FRANCE FR
Employees: 61
Phone: 33148240345
MAUNA KEA TECHNOLOGIES / ALMKT.PA FAQ
What does MAUNA KEA TECHNOLOGIES do?
Mauna Kea Technologies SA engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2011-07-05. The firm specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. The company provides Cellvizio product that is used by medical specialties and is revolutionizing the way physicians diagnose and treat patients making a transformative change in medicine. Its real-time in vivo cellular imaging platform, that delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time.
What is the stock price of MAUNA KEA TECHNOLOGIES today?
The current stock price of ALMKT.PA is 0.1738 EUR. The price increased by 4.57% in the last trading session.
Does MAUNA KEA TECHNOLOGIES pay dividends?
ALMKT.PA does not pay a dividend.
How is the ChartMill rating for MAUNA KEA TECHNOLOGIES?
ALMKT.PA has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What do analysts say about MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?
9 analysts have analysed ALMKT.PA and the average price target is 0.36 EUR. This implies a price increase of 105.41% is expected in the next year compared to the current price of 0.1738.
Can you provide the sector and industry classification for MAUNA KEA TECHNOLOGIES?
MAUNA KEA TECHNOLOGIES (ALMKT.PA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the next earnings date for ALMKT stock?
MAUNA KEA TECHNOLOGIES (ALMKT.PA) will report earnings on 2026-04-09, after the market close.